A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects

Recruiting

Phase 1 Results N/A

Summary of Purpose

This study is to evaluate the effect of dilitazem on the single-dose PK of BMS-986141 with parameters like Cmax, AUC(INF), and AUC(0-T).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 6 October 2016.

1 Sep 2016 30 Sep 2016 1 Nov 2016 1 Nov 2016 1 Oct 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Masking: Open Label
  • Purpose: Basic Science
  • Endpoint: Pharmacokinetics Study
  • Intervention: Single Group Assignment

Contacts

  • Recruiting sites have contact information. Please contact the sites directly. If there is no contact information, please email:

    Clinical.Trials@bms.com

  • First line of the email MUST contain NCT# and Site #.